Absence of Liner Following the Selective Caries Removal (ALFSCaRe) ((ALFSCaRe))

June 20, 2023 updated by: André Luis Faria e Silva, Universidade Federal de Sergipe

Is the Use of a Glass Ionomer Liner Necessary After Selective Carious Tissue Removal?

This randomized, multi-centric, controlled clinical trial will assess the effectiveness of a simplified restorative protocol used after the selective carious tissue removal in posterior teeth presenting deep carious lesions. Only a regular bulk-fill composite will be used in the simplified restorative protocol following the application of universal adhesive. A liner with resin-modified glass ionomer will be used over the pulpal floor before the composite placement in the control group. The longevity of restorative procedures and post-operative sensitivity were defined as the main and secondary outcomes.

Study Overview

Study Type

Interventional

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • SE
      • Aracaju, SE, Brazil, 49060100
        • Department of Dentistry/ Federal University of Sergipe

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

6 years to 40 years (Child, Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Molar presenting deep carious lesion;

Exclusion Criteria:

  • Non-vital teeth or teeth presenting pulpitis;
  • Cavity margins in dentin;
  • Presence of non-carious cervical lesions;
  • The necessity of restoration involving any cusp replacement.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Simplified restorative procedure
After selective carious tissue removal, the universal adhesive (Adper Universal; 3M ESPE, St. Paul, MN, EUA) will be applied on the cavity walls. The cavity will be restored using a single increment of Filtek One Bulk Fill (3M ESPE, St. Paul, MN, EUA).
Selective carious tissue removal followed by restoration of the cavity using composite resin.
Active Comparator: Control
A thin layer of resin-modified glass ionomer (Ionoseal (Voco America Inc., Briarcliff Manor, NY, EUA) will be placed on the pulpal floor of the cavity. Then, the adhesive and composite will be used following the same directions defined for the experimental condition.
Selective carious tissue removal followed by restoration of the cavity using composite resin.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Longevity of restoration
Time Frame: Annual evaluation during 5 years
Assessment of any failure in restorations according to the FDI World Dental Federation criteria.
Annual evaluation during 5 years

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Tooth sensitivity
Time Frame: 15 days after the restorative procedure
The participants will self-assess their level of tooth sensitivity of the restored teeth using a visual analogue scale of 0-10 (0 indicating absence of pain; and 10 the worst pain possible) oriented by both verbal description and Wong-Baker facial grimace scales.
15 days after the restorative procedure

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 30, 2019

Primary Completion (Actual)

November 1, 2020

Study Completion (Estimated)

September 1, 2024

Study Registration Dates

First Submitted

April 26, 2019

First Submitted That Met QC Criteria

April 26, 2019

First Posted (Actual)

May 1, 2019

Study Record Updates

Last Update Posted (Actual)

June 22, 2023

Last Update Submitted That Met QC Criteria

June 20, 2023

Last Verified

June 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • UFS/Prodonto

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Dental Restoration Failure of Marginal Integrity

Clinical Trials on Restoration of carious lesions

3
Subscribe